Article
Neuro-oncology: Isocitrate dehydrogenase mutations in low-grade gliomas.
Nature reviews. Neurology - 1 Jun 2009
Schiff David, Purow Benjamin W
Abstract excerpt
Most grade II and grade III gliomas, as well as the secondary glioblastomas that arise from these tumors, possess point mutations that affect the substrate binding site of isocitrate dehydrogenase. These mutations are essentially unique to gliomas, seem to represent an early step in gliomagenesis, and confer a favorable prognosis.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.